H Grant Skaggs Jr
Examiner (ID: 16447)
Most Active Art Unit | 3101 |
Art Unit(s) | 3651, 1301, 3615, 3653, 2899, 3101 |
Total Applications | 2062 |
Issued Applications | 1836 |
Pending Applications | 39 |
Abandoned Applications | 187 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 7361875
[patent_doc_number] => 20040091487
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-13
[patent_title] => 'Inhibition of HIV-1 virion production by a transdominant mutant of integrase interactor 1(INI1)/hSNF5'
[patent_app_type] => new
[patent_app_number] => 10/624080
[patent_app_country] => US
[patent_app_date] => 2003-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 20388
[patent_no_of_claims] => 90
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0091/20040091487.pdf
[firstpage_image] =>[orig_patent_app_number] => 10624080
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/624080 | Inhibition of HIV-1 virion production by a transdominant mutant of integrase interactor 1(INI1)/hSNF5 | Jul 20, 2003 | Issued |
Array
(
[id] => 7307474
[patent_doc_number] => 20040141984
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-22
[patent_title] => 'Amyloid beta 1-6 antigen arrays'
[patent_app_type] => new
[patent_app_number] => 10/622087
[patent_app_country] => US
[patent_app_date] => 2003-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 38589
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0141/20040141984.pdf
[firstpage_image] =>[orig_patent_app_number] => 10622087
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/622087 | Amyloid β1-6 antigen arrays | Jul 17, 2003 | Issued |
Array
(
[id] => 7374209
[patent_doc_number] => 20040219516
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-04
[patent_title] => 'Viral vectors containing recombination sites'
[patent_app_type] => new
[patent_app_number] => 10/622088
[patent_app_country] => US
[patent_app_date] => 2003-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 83
[patent_figures_cnt] => 83
[patent_no_of_words] => 142522
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20040219516.pdf
[firstpage_image] =>[orig_patent_app_number] => 10622088
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/622088 | Viral vectors containing recombination sites | Jul 17, 2003 | Abandoned |
Array
(
[id] => 6905567
[patent_doc_number] => 20050100962
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-12
[patent_title] => 'Detection of prion disease'
[patent_app_type] => utility
[patent_app_number] => 10/620090
[patent_app_country] => US
[patent_app_date] => 2003-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6397
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20050100962.pdf
[firstpage_image] =>[orig_patent_app_number] => 10620090
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/620090 | Detection of prion disease | Jul 14, 2003 | Abandoned |
Array
(
[id] => 5619396
[patent_doc_number] => 20060188929
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-24
[patent_title] => 'Method capable of being automated for detection of prpres and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/520397
[patent_app_country] => US
[patent_app_date] => 2003-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9140
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0188/20060188929.pdf
[firstpage_image] =>[orig_patent_app_number] => 10520397
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/520397 | Method capable of being automated for detection of prpres and uses thereof | Jul 7, 2003 | Abandoned |
Array
(
[id] => 5662322
[patent_doc_number] => 20060252918
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-09
[patent_title] => 'Use of hepatitis virus (hcv) p7 protein'
[patent_app_type] => utility
[patent_app_number] => 10/520550
[patent_app_country] => US
[patent_app_date] => 2003-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 4058
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0252/20060252918.pdf
[firstpage_image] =>[orig_patent_app_number] => 10520550
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/520550 | Use of hepatitis virus (hcv) p7 protein | Jul 6, 2003 | Abandoned |
Array
(
[id] => 5807717
[patent_doc_number] => 20060094071
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-04
[patent_title] => 'Method for enriching and tracking pathologic modified prions-proteins(prpsc)'
[patent_app_type] => utility
[patent_app_number] => 10/520386
[patent_app_country] => US
[patent_app_date] => 2003-07-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5012
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20060094071.pdf
[firstpage_image] =>[orig_patent_app_number] => 10520386
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/520386 | Method for enriching and tracking pathologic modified prions-proteins(prpsc) | Jul 3, 2003 | Abandoned |
Array
(
[id] => 7357703
[patent_doc_number] => 20040014034
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-22
[patent_title] => 'Method of producing a recombinant virus'
[patent_app_type] => new
[patent_app_number] => 10/455695
[patent_app_country] => US
[patent_app_date] => 2003-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 10904
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20040014034.pdf
[firstpage_image] =>[orig_patent_app_number] => 10455695
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/455695 | Method of producing a recombinant virus | Jun 5, 2003 | Abandoned |
Array
(
[id] => 5815241
[patent_doc_number] => 20060084791
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-20
[patent_title] => 'Purified polypeptide, isolated nucleic acids encoding said polypeptide, vectors and use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/514626
[patent_app_country] => US
[patent_app_date] => 2003-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 15764
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0084/20060084791.pdf
[firstpage_image] =>[orig_patent_app_number] => 10514626
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/514626 | Purified polypeptide, isolated nucleic acids encoding said polypeptide, vectors and use thereof | May 14, 2003 | Abandoned |
Array
(
[id] => 6701130
[patent_doc_number] => 20030224010
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-04
[patent_title] => 'Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant'
[patent_app_type] => new
[patent_app_number] => 10/434696
[patent_app_country] => US
[patent_app_date] => 2003-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 23154
[patent_no_of_claims] => 98
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20030224010.pdf
[firstpage_image] =>[orig_patent_app_number] => 10434696
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/434696 | Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant | May 8, 2003 | Abandoned |
Array
(
[id] => 5865453
[patent_doc_number] => 20060099583
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-11
[patent_title] => 'Compositions and methods for identifying antiviral agents'
[patent_app_type] => utility
[patent_app_number] => 10/512789
[patent_app_country] => US
[patent_app_date] => 2003-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 108
[patent_figures_cnt] => 108
[patent_no_of_words] => 11729
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20060099583.pdf
[firstpage_image] =>[orig_patent_app_number] => 10512789
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/512789 | Compositions and methods for identifying antiviral agents | May 6, 2003 | Abandoned |
Array
(
[id] => 7448930
[patent_doc_number] => 20040009942
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-15
[patent_title] => 'Methods of preventing and treating respiratory viral infection using immunomodulatory polynucleotide sequences'
[patent_app_type] => new
[patent_app_number] => 10/426237
[patent_app_country] => US
[patent_app_date] => 2003-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 14272
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20040009942.pdf
[firstpage_image] =>[orig_patent_app_number] => 10426237
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/426237 | Methods of preventing and treating respiratory viral infection using immunomodulatory polynucleotide sequences | Apr 28, 2003 | Abandoned |
Array
(
[id] => 6678432
[patent_doc_number] => 20030228573
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-11
[patent_title] => 'Antiviral inhibition of capsid proteins'
[patent_app_type] => new
[patent_app_number] => 10/420438
[patent_app_country] => US
[patent_app_date] => 2003-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 11697
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0228/20030228573.pdf
[firstpage_image] =>[orig_patent_app_number] => 10420438
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/420438 | Antiviral inhibition of capsid proteins | Apr 21, 2003 | Issued |
Array
(
[id] => 5732733
[patent_doc_number] => 20060257850
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-16
[patent_title] => 'Methods of treatment and diagnosis of patients with hepatitis c infection'
[patent_app_type] => utility
[patent_app_number] => 10/511415
[patent_app_country] => US
[patent_app_date] => 2003-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 14922
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0257/20060257850.pdf
[firstpage_image] =>[orig_patent_app_number] => 10511415
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/511415 | Methods of treatment and diagnosis of patients with hepatitis c infection | Apr 14, 2003 | Abandoned |
Array
(
[id] => 497384
[patent_doc_number] => 07208478
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-04-24
[patent_title] => 'Immunostimulatory polynucleotide/immunomodulatory molecule conjugates'
[patent_app_type] => utility
[patent_app_number] => 10/394387
[patent_app_country] => US
[patent_app_date] => 2003-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10698
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/208/07208478.pdf
[firstpage_image] =>[orig_patent_app_number] => 10394387
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/394387 | Immunostimulatory polynucleotide/immunomodulatory molecule conjugates | Mar 19, 2003 | Issued |
Array
(
[id] => 809831
[patent_doc_number] => 07416839
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-08-26
[patent_title] => '“Prionins”, highly specific markers for noninvasive presymptomatic detection of TSE diseases, and targets for therapeutic reagents to prevent and control TSE diseases in animals and humans'
[patent_app_type] => utility
[patent_app_number] => 10/386921
[patent_app_country] => US
[patent_app_date] => 2003-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 8436
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/416/07416839.pdf
[firstpage_image] =>[orig_patent_app_number] => 10386921
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/386921 | “Prioninsâ€, highly specific markers for noninvasive presymptomatic detection of TSE diseases, and targets for therapeutic reagents to prevent and control TSE diseases in animals and humans | Mar 11, 2003 | Issued |
Array
(
[id] => 5799368
[patent_doc_number] => 20060034869
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-16
[patent_title] => 'Drug for treating liver diseases with the use of hollow protein nanoparticles'
[patent_app_type] => utility
[patent_app_number] => 10/509252
[patent_app_country] => US
[patent_app_date] => 2003-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 4191
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20060034869.pdf
[firstpage_image] =>[orig_patent_app_number] => 10509252
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/509252 | Drug for treating liver diseases with the use of hollow protein nanoparticles | Mar 4, 2003 | Abandoned |
Array
(
[id] => 7150767
[patent_doc_number] => 20040171522
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-02
[patent_title] => 'Regulation of immune responses by manipulation of intermediary metabolite levels'
[patent_app_type] => new
[patent_app_number] => 10/375906
[patent_app_country] => US
[patent_app_date] => 2003-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4658
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20040171522.pdf
[firstpage_image] =>[orig_patent_app_number] => 10375906
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/375906 | Regulation of immune responses by manipulation of intermediary metabolite levels | Feb 26, 2003 | Abandoned |
Array
(
[id] => 7677756
[patent_doc_number] => 20040152070
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-05
[patent_title] => 'Method of detection of HCV antibodies in combination assay or sole antibody assay'
[patent_app_type] => new
[patent_app_number] => 10/357816
[patent_app_country] => US
[patent_app_date] => 2003-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8710
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20040152070.pdf
[firstpage_image] =>[orig_patent_app_number] => 10357816
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/357816 | Method of detection of HCV antibodies in combination assay or sole antibody assay | Feb 3, 2003 | Abandoned |
Array
(
[id] => 7408051
[patent_doc_number] => 20040106174
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-03
[patent_title] => 'Designing immunogens'
[patent_app_type] => new
[patent_app_number] => 10/326908
[patent_app_country] => US
[patent_app_date] => 2002-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 16828
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0106/20040106174.pdf
[firstpage_image] =>[orig_patent_app_number] => 10326908
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/326908 | Designing immunogens | Dec 22, 2002 | Abandoned |